vs
Side-by-side financial comparison of HARTE HANKS INC (HHS) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $39.9M, roughly 1.4× HARTE HANKS INC). LandBridge Co LLC runs the higher net margin — 14.2% vs 5.5%, a 8.7% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -15.4%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-686.0K). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs -6.4%).
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
HHS vs LB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $39.9M | $56.8M |
| Net Profit | $2.2M | $8.1M |
| Gross Margin | — | — |
| Operating Margin | -0.3% | 60.0% |
| Net Margin | 5.5% | 14.2% |
| Revenue YoY | -15.4% | 55.6% |
| Net Profit YoY | — | -83.7% |
| EPS (diluted) | $0.30 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.9M | $56.8M | ||
| Q3 25 | $39.5M | $50.8M | ||
| Q2 25 | $38.6M | $47.5M | ||
| Q1 25 | $41.6M | $44.0M | ||
| Q4 24 | $47.1M | $36.5M | ||
| Q3 24 | $47.6M | $28.5M | ||
| Q2 24 | $45.0M | $26.0M | ||
| Q1 24 | $45.4M | $19.0M |
| Q4 25 | $2.2M | $8.1M | ||
| Q3 25 | $-2.3M | $8.1M | ||
| Q2 25 | $-335.0K | $7.5M | ||
| Q1 25 | $-392.0K | $6.5M | ||
| Q4 24 | — | $49.3M | ||
| Q3 24 | $142.0K | $2.7M | ||
| Q2 24 | $-27.8M | $-57.7M | ||
| Q1 24 | $-171.0K | $10.8M |
| Q4 25 | -0.3% | 60.0% | ||
| Q3 25 | 1.3% | 60.8% | ||
| Q2 25 | 0.1% | 60.0% | ||
| Q1 25 | -0.1% | 57.0% | ||
| Q4 24 | -3.3% | 49.4% | ||
| Q3 24 | 4.0% | 11.2% | ||
| Q2 24 | 3.0% | -197.4% | ||
| Q1 24 | 0.8% | 71.1% |
| Q4 25 | 5.5% | 14.2% | ||
| Q3 25 | -5.8% | 15.9% | ||
| Q2 25 | -0.9% | 15.8% | ||
| Q1 25 | -0.9% | 14.7% | ||
| Q4 24 | — | 135.2% | ||
| Q3 24 | 0.3% | 9.3% | ||
| Q2 24 | -61.8% | -222.1% | ||
| Q1 24 | -0.4% | 56.7% |
| Q4 25 | $0.30 | $0.24 | ||
| Q3 25 | $-0.31 | $0.26 | ||
| Q2 25 | $-0.05 | $0.24 | ||
| Q1 25 | $-0.05 | $0.20 | ||
| Q4 24 | $-0.31 | — | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $-3.84 | — | ||
| Q1 24 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $30.7M |
| Total DebtLower is stronger | — | $570.7M |
| Stockholders' EquityBook value | $20.5M | $340.3M |
| Total Assets | $91.8M | $1.4B |
| Debt / EquityLower = less leverage | — | 1.68× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $30.7M | ||
| Q3 25 | $6.5M | $28.3M | ||
| Q2 25 | $4.8M | $20.3M | ||
| Q1 25 | $9.0M | $14.9M | ||
| Q4 24 | $9.8M | $37.0M | ||
| Q3 24 | $5.9M | $14.4M | ||
| Q2 24 | $11.0M | $24.6M | ||
| Q1 24 | $11.5M | — |
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M | ||
| Q1 24 | — | — |
| Q4 25 | $20.5M | $340.3M | ||
| Q3 25 | $19.9M | $272.0M | ||
| Q2 25 | $22.2M | $266.4M | ||
| Q1 25 | $21.4M | $217.0M | ||
| Q4 24 | $21.7M | $211.8M | ||
| Q3 24 | $21.0M | $97.2M | ||
| Q2 24 | $20.6M | $296.4M | ||
| Q1 24 | $20.0M | $162.3M |
| Q4 25 | $91.8M | $1.4B | ||
| Q3 25 | $92.7M | $1.1B | ||
| Q2 25 | $95.0M | $1.1B | ||
| Q1 25 | $100.6M | $1.0B | ||
| Q4 24 | $101.8M | $1.0B | ||
| Q3 24 | $108.1M | $689.9M | ||
| Q2 24 | $109.7M | $710.5M | ||
| Q1 24 | $113.4M | — |
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $737.0K | $126.3M |
| Free Cash FlowOCF − Capex | $-686.0K | $122.0M |
| FCF MarginFCF / Revenue | -1.7% | 214.9% |
| Capex IntensityCapex / Revenue | 3.6% | 7.5% |
| Cash ConversionOCF / Net Profit | 0.33× | 15.68× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.5M | $207.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.0K | $126.3M | ||
| Q3 25 | $3.2M | $34.9M | ||
| Q2 25 | $-4.8M | $37.3M | ||
| Q1 25 | $-818.0K | $15.9M | ||
| Q4 24 | $4.0M | $67.6M | ||
| Q3 24 | $-2.9M | $7.5M | ||
| Q2 24 | $1.6M | $16.0M | ||
| Q1 24 | $-5.7M | $17.2M |
| Q4 25 | $-686.0K | $122.0M | ||
| Q3 25 | $2.2M | $33.7M | ||
| Q2 25 | $-5.1M | $36.1M | ||
| Q1 25 | $-923.0K | $15.8M | ||
| Q4 24 | $3.4M | $66.7M | ||
| Q3 24 | $-4.9M | $7.1M | ||
| Q2 24 | $926.0K | $15.7M | ||
| Q1 24 | $-6.2M | $17.1M |
| Q4 25 | -1.7% | 214.9% | ||
| Q3 25 | 5.5% | 66.3% | ||
| Q2 25 | -13.1% | 75.9% | ||
| Q1 25 | -2.2% | 36.0% | ||
| Q4 24 | 7.3% | 182.6% | ||
| Q3 24 | -10.2% | 25.1% | ||
| Q2 24 | 2.1% | 60.4% | ||
| Q1 24 | -13.7% | 90.1% |
| Q4 25 | 3.6% | 7.5% | ||
| Q3 25 | 2.5% | 2.3% | ||
| Q2 25 | 0.6% | 2.6% | ||
| Q1 25 | 0.3% | 0.2% | ||
| Q4 24 | 1.3% | 2.7% | ||
| Q3 24 | 4.0% | 1.1% | ||
| Q2 24 | 1.5% | 1.4% | ||
| Q1 24 | 1.2% | 0.5% |
| Q4 25 | 0.33× | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | -20.76× | 2.80× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
LB
Segment breakdown not available.